DV
Dividend Vision

KRRO — Korro Bio, Inc.

Korro Bio, Inc. (KRRO)

Total return is -98.1% over the past 6.9 years, 292.8 points behind SPY at 194.7%. Its deepest 1-year drawdown was 89.7%.

KRRO is an equity stock fund focused on Korro Bio, Inc., a specialized life sciences company. The fund lacks a stated dividend distribution rate and does not report regular income distributions, making it primarily oriented toward capital appreciation rather than dividend income. This fund appeals to investors seeking exposure to the biotech sector rather than those targeting dividend yield.

KRRO key facts

Asset type
Stock
Asset class
Equity
Inception date
10/03/2019
Last close
$13.28
Market cap
$165,859,568
Average volume
47074.0
Beta
2.106
Payout ratio
0.0
Forward P/E
0.0
EPS
$-11.01